ACTRN12610000264088
Recruiting
未知
Evaluation of the operational performance of the revised World Health Organization (WHO) recommendations and algorithms for improving the diagnosis of tuberculosis in human immunodeficiency virus prevalent settings, Ethiopia
nited Nations Children's Fund/United Development Program/World Health Organization/World Bank-Research and Training in Tropical Diseases(TDR)0 sites3,236 target enrollmentMarch 31, 2010
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Tuberculosis(TB)
- Sponsor
- nited Nations Children's Fund/United Development Program/World Health Organization/World Bank-Research and Training in Tropical Diseases(TDR)
- Enrollment
- 3236
- Status
- Recruiting
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Settings which had TB culture facility will be included to implement the 2006 WHO TB guideline. TB suspects who are above 15 years will be included.
Exclusion Criteria
- •Tuberculosis suspects below 15 years will be excluded
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
An Investigation to Evaluate the Performance of the Cepheid Xpert® HIV-1 VL XC TestHIV/AIDSPACTR201908919241847Cepheid800
Not yet recruiting
Not Applicable
Pivotal trial to evaluate an Artificial intelligence (AI) diabetic retinopathy grading classifier in the New Zealand population undergoing regular screening for diabetic retinopathy.DiabetesDiabetic retinopathyMetabolic and Endocrine - DiabetesEye - Diseases / disorders of the eyeACTRN12620000488909Dr David Squirrell1,000
Active, not recruiting
Phase 1
Evaluation de l'efficacité et de la tolérance de rosuvastatine 5 mg versus pravastatine 40 mg et atorvastatine 10 mg chez des patients hypercholestérolémiques de type IIa et IIbHypercholestérolémies de type IIa et IIbMedDRA version: 9.1Level: LLTClassification code 10020602Term: HypercholesteremiaEUCTR2006-006697-15-FRAstraZeneca SAS1,150
Recruiting
Not Applicable
Safety and Technical Performance Evaluation of the Emboliner Embolic Protection Device: A New Zealand ExperienceTranscatheter aortic valve replacementEmbolic protectionCardiovascular - Other cardiovascular diseasesACTRN12622000473763Emboline, Inc.20
Completed
Not Applicable
Preliminary effectiveness and feasibility of the RISE intervention to reduce and interrupt sedentary behaviour in community dwelling sedentary people after stroke.Cardiovasculair, beroerteSedendary behavriour after strokesitting time after stroke10024450NL-OMON55033niversitair Medisch Centrum Utrecht12